A detailed history of Sapient Capital LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Sapient Capital LLC holds 28,676 shares of ABT stock, worth $3.28 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares
28,676
Previous 28,933 0.89%
Holding current value
$3.28 Million
Previous $3.01 Million 8.75%
% of portfolio
0.07%
Previous 0.06%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 11, 2024

SELL
$100.07 - $118.13 $25,717 - $30,359
-257 Reduced 0.89%
28,676 $3.27 Million
Q2 2024

Jul 15, 2024

SELL
$100.73 - $112.44 $170,032 - $189,798
-1,688 Reduced 5.51%
28,933 $3.01 Million
Q1 2024

Apr 22, 2024

SELL
$109.52 - $120.96 $7.75 Million - $8.56 Million
-70,808 Reduced 69.81%
30,621 $3.48 Billion
Q4 2023

Feb 06, 2024

BUY
$90.19 - $110.4 $80,269 - $98,256
890 Added 0.89%
101,429 $11.2 Billion
Q4 2023

Jan 29, 2024

BUY
$90.19 - $110.4 $9.07 Million - $11.1 Million
100,539 New
100,539 $11.1 Billion

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $200B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Sapient Capital LLC Portfolio

Follow Sapient Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sapient Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sapient Capital LLC with notifications on news.